Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)

BACKGROUND: Immune-Oncology (IO) improves Overall Survival (OS) in metastatic Renal Cell Carcinoma (mRCC). The prognostic impact of previous Cytoreductive Nephrectomy (CN) and radical nephrectomy (RN), with curative intent, in patients treated with IO is not well defined. The aim of our paper is to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Stellato, Marco, Santini, Daniele, Verzoni, Elena, De Giorgi, Ugo, Pantano, Francesco, Casadei, Chiara, Fornarini, Giuseppe, Maruzzo, Marco, Sbrana, Andrea, Di Lorenzo, Giuseppe, Soraru, Mariella, Naglieri, Emanuele, Buti, Sebastiano, De Vivo, Rocco, Napolitano, Andrea, Vignani, Francesca, Mucciarini, Claudia, Grillone, Francesco, Roviello, Giandomenico, Di Napoli, Marilena, Procopio, Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8217989/
https://ncbi.nlm.nih.gov/pubmed/34168997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.682449
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars